CPT® Code 86769 is used to report an antibody test for SARS-CoV-2, the virus that causes COVID-19. The test detects antibodies produced in response to the virus and may be used as part of an evaluation of prior or recent exposure.
Antibody testing is different from molecular or antigen testing, which is generally used to detect current infection.
Key Facts About CPT® 86769
- Service type: Laboratory immunology test
- Test: SARS-CoV-2 antibody testing
- Target: Antibodies to SARS-CoV-2
- Specimen: Typically blood, serum, or plasma
- Purpose: Detect an immune response to SARS-CoV-2
- Provider type: Physician, qualified healthcare professional, or laboratory
Common clinical uses may include:
- Evaluation of prior SARS-CoV-2 exposure
- Serologic assessment when clinically appropriate
- Public health or epidemiologic testing when applicable
- Evaluation of antibody status in specific clinical circumstances
When to Use CPT® 86769
CPT 86769 may be reported when a laboratory performs the applicable SARS-CoV-2 antibody test.
Examples:
- Evaluating whether a patient has developed antibodies following suspected prior exposure
- Performing serologic testing when clinically indicated
- Documenting SARS-CoV-2 antibody results as part of a patient's medical evaluation
An antibody test does not by itself establish that a patient currently has an active COVID-19 infection.
Documentation Requirements
Documentation supporting CPT 86769 should include:
- Patient identifiers and date of service
- Clinical indication for antibody testing
- Relevant exposure or infection history, when applicable
- SARS-CoV-2 antibody test ordered or performed
- Test result and applicable reference information
- Assessment and interpretation of the result
- Follow-up recommendations, when appropriate
Clear documentation helps establish the reason for testing and supports appropriate laboratory coding.
Reimbursement and Coding Considerations
- CPT 86769 represents SARS-CoV-2 antibody testing
- It should be distinguished from tests designed to detect active SARS-CoV-2 infection
- Coverage and medical-necessity requirements vary by payer and clinical circumstance
- Practices should verify current payer policies before submitting claims
- Antibody results should be interpreted in the context of the patient's history, symptoms, vaccination history, and other clinical information when relevant
Accurate documentation of the test performed and its clinical indication helps support appropriate coding and billing.
How OptiMantra Supports Laboratory Testing Documentation
OptiMantra helps practices organize laboratory orders, results, clinical findings, and follow-up information within the patient chart.
With OptiMantra, providers can:
- Document SARS-CoV-2 antibody testing and clinical indications
- Record laboratory results within the patient's medical record
- Maintain relevant exposure and medical history
- Link laboratory findings to diagnoses and treatment plans
- Document follow-up recommendations based on test results
- Maintain organized longitudinal patient records
Keeping laboratory results connected to the patient's clinical record helps providers maintain comprehensive documentation for ongoing care.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
